Sasha Lu Austin - 02 Feb 2026 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: VP of Finance and Controller
Signature: /s/ Shawnte Mitchell, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2026, 21:35:05 UTC
Previous filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Austin Sasha Lu	VP of Finance and Controller	C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN STREET, SAN FRANCISCO	/s/ Shawnte Mitchell, Attorney-in-Fact	17 Feb 2026	0002110895

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Award	$0	+11,700	+261%	$0.000000	16,188	02 Feb 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Award	$0	+29,250		$0.000000	29,250	02 Feb 2026	Common Stock	29,250	$25.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vest on February 2, 2027, and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.